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ABSTRACT
BACKGROUND AND PURPOSE: Various tumors of the sinonasal tract can exhibit high signal intensity on T1WI. The purpose of this study
was to determine the value of a septate pattern on precontrast T1WI for diagnosing sinonasal melanoma.
MATERIALS AND METHODS: Retrospectively, 3 observers independently reviewed MR images of 31 histologically proved sinonasal
melanomas with special attention to the presence or absence of a septate pattern on precontrast T1WI, deﬁned as alternating hyperin-
tense and hypointense striations on precontrast T1WI. For comparison, we evaluated the prevalence of a septate pattern on precontrast
T1WI in 106 nonmelanomatous sinonasal malignant tumors with 16 different histologic types. We also tried to identify the histopathologic
features responsible for the septate pattern on precontrast T1WI.
RESULTS: Twenty-seven (87.1%) of 31 sinonasal melanomas showed hyperintense foci on T1WI, among which a septate pattern on
precontrast T1WI was seen in 23 (74.2%), while 22 (20.8%) of 106 nonmelanomatous malignant tumors demonstrated hyperintense foci on
T1WI, among which only 3 (2.8%) showed a septate pattern on precontrast T1WI. The sensitivity, speciﬁcity, positive predictive value,
negative predictive value, and accuracy of a septate pattern on precontrast T1WI for the diagnosis of sinonasal melanoma were 74%, 97%,
88%, 93%, and 92%, respectively. Although limited due to the retrospective nature, 4 of 23 histologically reviewed sinonasal melanomas
revealed an uneven distribution of melanin with alternating melanin and ﬁbrous bands within the tumors.
CONCLUSIONS: A septate pattern on precontrast T1WI might be an adjunctive imaging ﬁnding for the diagnosis of sinonasal melanoma.
This might be attributed histologically to an uneven distribution of melanin and hemorrhage within the tumors.
ABBREVIATIONS: SNM sinonasal melanoma; T1-SP septate pattern on precontrast T1-weighted MR imaging
Melanoma of the sinonasal tract roughly accounts for1%ofall melanomas and up to 4% of all sinonasal malignan-
cies.1-5 According to the Surveillance, Epidemiology, and EndRe-
sults data base, the approximate incidence of mucosal melanoma
of the head and neck was 0.6–1.2 cases per million persons per
year from 1987 to 2009 in the United States.6 Of these, 72.6% of
patients had disease in the sinonasal location.6 The incidence of
mucosal melanoma appears to be increasing, especially in the si-
nonasal tract.6,7
Previous studies described high signal intensity on T1WI and
low signal intensity on T2WI as the characteristic MR imaging
features of melanoma. The signal characteristics on MR images
are attributed to the paramagnetic properties of melanin pig-
ment.8-13 However, several substances besides melanin, such as
hemorrhage, high proteinaceous secretions, and fungus can also
generate high signal intensity on T1WI.12,14 In some respects,
sinonasal melanoma (SNM) is distinct from other malignant si-
nonasal tumors. First, the prognosis of SNM is reportedly much
worse than othermalignant sinonasal tumors,15-17 with its overall
5-year survival rates being estimated at 30% in most series,3
while those of other sinonasal malignancies range from 22% to
67%, with an average of 45.5%.16 Since 2010, the American Joint
Committee on Cancer has created a separate system for staging
mucosal melanoma of the head and neck, in which a primary
tumor limited to the mucosa is considered T3, which reflects
the aggressive biologic behavior of the tumor.18 Second, SNM
Received July 24, 2017; accepted after revision November 20.
From the Departments of Radiology (Y.-K.K., H.-J.K., H.Y.K., G.M.P., J.C., S.T.K.) and
Pathology (Y.-H.K.), Samsung Medical Center, Sungkyunkwan University School of
Medicine, Seoul, Korea; Department of Radiology (J.W.C.), Ajou University School
of Medicine, Suwon, Korea; Department of Radiology (G.M.P.), Ulsan University
Hospital, University of Ulsan College of Medicine, Ulsan, Korea; and Department of
Radiology and Research Institute of Radiological Science (J.C.), College of Medi-
cine, Yonsei University College of Medicine, Seoul, Korea.
Yi-Kyung Kim and Jin Wook Choi contributed equally to this work.
Please address correspondence to Hyung-Jin Kim, MD, Department of Radiology,
Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-
ro, Gangnam-gu, Seoul 135-710, Korea; e-mail: hyungkim@skku.edu
http://dx.doi.org/10.3174/ajnr.A5539
762 Kim Apr 2018 www.ajnr.org
frequently presents as a mass with multicentric distribution.19
Third, promising results are constantly being reported on the ef-
ficacy of targeted therapy for treating advanced SNMs, including
biochemotherapy using cytotoxic chemotherapy and biologic im-
munomodulatory agents such as interferon  and interleukin
2.3,20,21 The purpose of this study was to evaluate the diagnostic
value of the septate pattern on precontrast T1-weighted MR im-




This studywas approved by the institutional review board at Sam-
sungMedical Center, and informed consent was waived in accor-
dance with the requirements of a retrospective study.
Between January 1998 and January 2015, a search of the elec-
tronic medical records of our hospital revealed 56 patients (male/
female ratio  34:22; mean age, 62 years; range, 21–88 years)
with histologically proved SNM, among
whom MR imaging was performed in
35. Four patients were excluded from
the study because no mass could be lo-
calized on MR images, resulting in 31
patients who were subjects of this study.
There were 18men and 13 women rang-
ing in age from 37 to 88 years (mean age,
64 years).
To validate the role of T1-SP for di-
agnosing SNMs, we selected MR images
of 106 adult patients with 16 different
types of nonmelanomatous malignant
sinonasal tumors through a search of the
electronic data base of our institution
between January 2010 and December
2014 using the keywords “malignant tu-
mor of the nose and paranasal sinuses.”
All tumors were diagnosed histologi-
cally by biopsy and/or an operation.
These 106 patients consisted of 63
males and 43 females with ages rang-
ing from 14 to 87 years (mean age,
56 years). Table 1 demonstrates the
pathologic subtypes, of which squamous cell carcinoma wasmost
common (n  45), followed by lymphoma (n  22), adenoid
cystic carcinoma (n  10), and other sinonasal malignancies
(n 29).
MR Imaging
MR imaging examinations were performed on a 1.5T (Signa Ad-
vantage or Horizon; GE Healthcare, Milwaukee, Wisconsin) or
3T (Intera Achieva; Philips Healthcare, Best, the Netherlands)
scanner. In all patients, precontrast spin-echo TIWI (TR/TE/
NEX, 400–560 ms/10–14 ms/2) and fast spin-echo T2WI (TR/
TE/NEX, 2500–4500 ms/80–110 ms/1) with or without fat satu-
ration were obtained, followed by contrast-enhanced spin-echo
T1WI with fat saturation after the intravenous injection of 0.1
mmol/kg of gadolinium-based contrastmaterial. Imageswere ob-
tained in at least 2 planes with 3- to 4-mm section thickness and 0-
to 1-mm intersection gap.
Image Analysis
All MR images were evaluated by 3 radiologists with 4, 2, and 2
years of experience in neuroradiology, respectively, in an anony-
mized and randomizedmanner. All reviewers were blinded to the
final histologic diagnosis. We evaluated the general MR imaging
features of SNMs, such as the signal intensity and enhancement
pattern. We determined the presence or absence of a T1-SP on
MR imaging in 31 SNMs and 106 nonmelanomatous malignant
sinonasal tumors. A T1-SP was determined to be present if a reg-
ular pattern of the alternating hyperintense and hypointense stri-
ations was distributed partially or diffusely within the solid
components of the tumor on unenhanced T1WI (Fig 1A). Hyper-
intense foci without a regular pattern of alternating striations
were not considered a T1-SP (Fig 1B). Before image review, the
observers were instructed and tested on the imaging appearance
FIG 1. Two different types of SNM containing high signal intensity on
T1WI with the presence (A) or absence (B) of a T1-SP. Although both
tumors have intrinsic high signal intensity, only A demonstrates a
regular pattern of the alternating hyperintense and hypointense stri-
ations, so-called T1-SP (arrows). In contrast, the high signal intensity in
B appears amorphous without the alternating hyperintense and hy-
pointense striations in a regular pattern (asterisks).
Table 1: Visualization of a T1-SP on MR imaging in sinonasal melanomas and
nonmelanomatous malignant sinonasal tumors based on consensus readinga
Total
Hyperintense Foci on T1WI
Present
AbsentT1-SP (+) T1-SP (−)
Sinonasal melanomab 31 23 4 4
Nonmelanomatous malignant tumorb 106 3 19 84
Squamous cell carcinoma 45 2 6 37
Lymphoma 22 1 2 19
Adenoid cystic carcinoma 10 0 4 6
Rhabdomyosarcoma 5 0 0 5
Neuroendocrine carcinoma 4 0 2 2
Adenocarcinoma 4 0 2 2
Malignant ﬁbrous histiocytoma 3 0 1 2
Poorly differentiated carcinoma 3 0 0 3
Spindle cell sarcoma 3 0 0 3
Esthesioneuroblastoma 1 0 0 1
Small round cell sarcoma 1 0 1 0
Inﬂammatory myoﬁbroblastic sarcoma 1 0 0 1
Malignant peripheral nerve sheath tumor 1 0 0 1
Ewing sarcoma 1 0 1 0
Chondrosarcoma 1 0 0 1
Myoepithelial carcinoma 1 0 0 1
Note:— indicates presence;, absence.
a Data are presented as number of tumors.
b P value .001 by the Fisher exact test.
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of a T1-SP.MR imaging interpretation proceeded in 2 ways: First,
each observer independently reviewed the images in a random-
ized fashion; and second, the 3 observers reached a consensus by a
joint interpretation that followed individual interpretation 1
month later to minimize recall bias.
Histopathologic Evaluation
Histopathologic slides were available for review in 23 of 31 SNMs.
A board-certified pathologist with 30 years of experience in head
and neck pathology retrospectively re-examined the pathologic
slides with special attention to the presence or absence ofmelanin,
the presence or absence of intratumoral hemorrhage, and the pre-
dominant cell type. The tumors were grouped intomelanotic and
amelanotic tumors with the former being further categorized as
those with abundant melanin when the melanin-containing cells
exceeded 10% of tumor cells and those with a moderate amount
of melanin when they composed10%. Finally, we tried to iden-
tify the histopathologic features responsible for T1-SP.
Statistical Analysis
On the basis of the observations made by each observer, interob-
server agreement among 3 observers was evaluated by calculating
 statistics. A  value  0.20 indicated positive but poor agree-
ment; 0.21–0.40, fair agreement; 0.41–0.60,moderate agreement;
0.61–0.80, good agreement; and 0.81, excellent agreement. On
the basis of the results made by the 3 observers’ consensus inter-
pretations, the statistical difference of a T1-SP between SNMs and
other malignant sinonasal tumors was analyzed using the Fisher
exact test. We also determined the overall sensitivity, specificity,
positive predictive value, negative predictive value, and accuracy
of a T1-SP as the diagnostic indicator of SNM. The statistical
differences in the prevalence of a T1-SP were sought according to
the presence or absence of melanin, the presence or absence of
hemorrhage, and the different cell types using the 2 test. During
statistical analysis, differences of P .05 were considered statisti-
cally significant.
RESULTS
Compared with the brain stem, 26 of 31 SNMs showed heteroge-
neous isointense and hyperintense signal intensity on T1WI,
while 5 tumors demonstrated homogeneous hypointense (n 1)
or heterogeneous isointense and hyperintense (n  4) signal in-
tensity. Various signal intensities were demonstrated on T2WI,
including heterogeneous isointense and hypointense signal inten-
sity (n  15), heterogeneous isointense and hyperintense signal
intensity (n  9), and heterogenous hypointense and hyperin-
tense signal intensity (n 7). Twenty-seven tumors were gener-
ally well-enhanced on contrast-enhanced T1WI, while the re-
maining 4 tumors showed poor enhancement. Only 2 tumors
demonstrated intratumoral necrosis.
Comparison of the Prevalences of T1-SP between SNMs
and Other Malignant Tumors
On the basis of the results of individual and consensus interpre-
tations, we summarized the prevalences of a T1-SP in SNMs and
other nonmelanomatous sinonasal malignant tumors in Tables 1
and 2. Interobserver agreement among 3 observers for the pres-
ence of a T1-SP was good, with an average  value of 0.71.
According to a consensus reading by the 3 observers, there was
a significant statistical difference in the prevalence of a T1-SP
between SNMs and other malignant tumors (P .001). Twenty-
seven (87.1%) of 31 SNMs showed hyperintense foci on T1WI,
among which a T1-SP was seen in 23 (74.2%), either diffusely
(n 7, Fig 2) or partially (n 16, Fig 3). In contrast, 22 (20.8%)
of 106 nonmelanomatous malignant sinonasal tumors demon-
strated hyperintense foci on T1WI, among which only 3 (2.8%)
showed a T1-SP. These 3 tumors included 2 of 45 squamous cell
carcinomas (Fig 4A) and 1 of 14 lymphomas (Fig 4B). Overall, the
sensitivity, specificity, positive predictive value, negative predic-
tive value, and accuracy of a T1-SP for the diagnosis of SNMwere
74% (95% CI, 55%–88%), 97% (95% CI, 92%–99%), 88% (95%
CI, 71%–96%), 93% (95% CI, 88%–96%), and 92% (95% CI,
83%–96%), respectively.
Histopathologic Features of SNMs in Correlation with MR
Imaging Features
Of 23 SNMs for which retrospective histopathologic analysis was
available, 18 tumorsweremelanotic and 5were amelanotic. Over-
all, intratumoral hemorrhage was present in 14 and absent in 9.
FIG 2. SNM in the right frontal sinus displaying a diffuse T1-SP. Pre-
contrast T1WI demonstrates a mass with the alternating hyperintense
and hypointense bands, the so-called T1-SP.
Table 2: Summary of the results of MR imaging interpretation by 3 observersa
Presence or Absence of T1-SP
Observer 1 Observer 2 Observer 3 Overallb
+ − + − + − + −
Sinonasal melanoma 22 9 26 5 20 11 23 8
Nonmelanomatous malignant sinonasal tumors 7 99 1 105 3 103 3 103
Note:— indicates presence;, absence.
a Interobserver agreement between observers 1 and 2,  .69; between observers 1 and 3,  0.72; between observers 2 and 3,  0.71; average,  0.71.
b Data were obtained by consensus interpretation of 3 observers.
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Various histologic cell types were seen, including 15 epithelioid
cell, 3 spindle cell, and 5 mixed cell types. Correlation of the his-
topathologic features with the MR imaging features in these 23
SNMs in terms of the presence or absence of a T1-SP is summa-
rized in Table 3. A T1-SP was found in 14 of 18 melanotic mela-
nomas and 4 of 5 amelanotic melanomas. Twelve of 14 tumors
with intratumoral hemorrhage had a T1-SP, while 6 of 9 tumors
without hemorrhage demonstrated it. There was no significant
statistical difference in the prevalence of a T1-SP among tumors
regarding the presence of melanin (P  .915), the presence of
hemorrhage (P  .280), and the different cell types (P  .399).
Melanin pigments were abundant in 9 of 18 melanotic tumors
and moderate in the remaining 9 tumors. If melanotic tumors
with moderate melanin and amelanotic tumors were grouped to-
gether, there was a significant statistical difference in the preva-
lence of a T1-SP between the group of tumors with no and mod-
eratemelanin andmelanotic tumorswith abundantmelanin (P
.043 using the 2 test), suggestive of a close relationship between
the amount of melanin and the presence of T1-SP. Hemorrhage
was present in 10 of 18 melanotic tumors and 4 of 5 amelanotic
tumors. T1-SP was demonstrated in 1 amelanotic melanoma that
had no hemorrhage on histologic examination.
Although the retrospective nature of this study kept us from
performing a side-by-side MR imaging–pathologic correlation, 4
cases revealed an uneven distribution of melanin with alternating
melanin and fibrous bands, whichmight be considered one of the
pathologic features responsible for a T1-SP on MR imaging (Fig
3C, -D).
DISCUSSION
The results of the present study are promising in that a T1-SP
might be a useful imaging marker for the diagnosis of SNM with
high specificity (97%) and amoderate sensitivity (74%).While 23
FIG 3. SNM displaying a partial T1-SP. A, Precontrast axial T1WI dem-
onstrates an elongated mass with heterogeneous signal intensity in
the left nasal cavity.While the anterior portion of themass shows the
alternating hyperintense and hypointense bands, the so-called T1-SP
(arrow), the posterior portion is the soft-tissue component with the
signal intensity isointense to the brain stem (asterisks). B, On fat-
suppressed axial T2WI, the anterior portion of themass appears isoin-
tense to the brain stem (arrow), while the posterior portion becomes
hyperintense (asterisks). Insufﬁcient facial and buccal fat suppression
was caused by magnetic ﬁeld inhomogeneity due to metallic dental
hardware. C. Photomicrograph reveals an uneven distribution of mel-
anin pigments (dark bands marked with asterisks). The bar on the left
bottom indicates 3 mm (hematoxylin-eosin, original magniﬁcation
7). D, Photomicrograph with higher magniﬁcation corresponding to
the box in C shows the area of the alternating melanin (dark bands
marked with asterisks) and ﬁbrous (f) bands. The bar on the left bot-
tom indicates 700 m (hematoxylin-eosin, original magniﬁcation
30).
FIG 4. Examples of nonmelanomatous sinonasal tumors displaying a
T1-SP (arrows). A, Squamous cell carcinoma. B, Lymphoma.
Table 3: Correlation of histopathologic and MR imaging features
of 23 sinonasal melanomasa
T1-SP (+) T1-SP (−) P Valueb
Melanin .915











Note:— indicates presence;, absence.
a Data are presented as numbers of tumors.
b Comparison of the prevalence of a T1-SP according to the presence of melanin, the
presence of hemorrhage, and the different cell types using the 2 test.
c Comparison of the prevalence of a T1-SP between tumors with abundant melanin
and the group of tumors with no and moderate melanin by the 2 test.
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(74.2%) of 31 SNMs showed a T1-SP, only 3 (2.8%) of 106 non-
melanomatous malignant tumors demonstrated it. It also proved
to be reproducible, shown by good interobserver agreement.
In this study, 14 of 18 melanotic SNMs and 4 of 5 amelanotic
SNMs demonstrated a T1-SP. Although we failed to reveal a sig-
nificant statistical difference in the prevalence of a T1-SP between
melanotic and amelanotic tumors, our results showing a signifi-
cant higher prevalence of a T1-SP in SNMs compared with other
nonmelanomatous tumors may still be good evidence that mela-
nin pigment is the important source for T1-SP. In their studywith
7 melanotic SMMs and 5 amelanotic SMMs, Yousem et al11 re-
ported that allmelanotic tumorswere hyperintense to graymatter
on T1WI regardless of the presence of hemorrhage, while the sig-
nal intensities of all amelanotic tumors were intermediate on
T1WI. They suggested that the presence of melanin should be
considered the main cause of hyperintensity.11
We also failed to find any statistical significance of the preva-
lence of a T1-SP between hemorrhagic and nonhemorrhagic tu-
mors and among tumors of the different cell types as well. In their
study with 6 melanotic SNMs and 5 amelanotic SNMs, Kim et al9
suggested that the signal intensity of SNMs on MR imaging was
affected mainly by melanin pigments but also, in part, by the
hemorrhagic products. We speculate that intratumoral hemor-
rhage in addition tomelanin should play a role in creating a T1-SP
in a certain proportion of SNMs, as seen in 4 amelanotic SNMs
and 3 nonmelanomatous sinonasal tumors demonstrating a
T1-SP in this study. Most interesting, we found an intimate rela-
tionship between the amount of melanin and the presence of
a T1-SP. Although no statistical difference in the prevalence of a
T1-SP was found between melanotic and amelanotic tumors, the
difference was significant between tumors with abundant mela-
nin and the group of tumors with no andmoderate melanin. This
finding is in accordance with the results of the study by Kim et al,9
who reported that the signal intensity pattern could vary on MR
imaging depending on the amount and distribution of melanin
within individual SNMs.
Previous studies also found intratumoral vessels and fibrous
septawithinmalignantmelanomas onhistologic examination.9,22
We suggest that a T1-SPmay be attributed to an uneven distribu-
tion of melanin and hemorrhage within the tumors. In this study,
1 amelanotic tumor without evidence of hemorrhage demon-
strated a T1-SP. Although unclear, it is possible that insufficient
histopathologic examinationmight have overlooked the presence
of melanin and/or hemorrhage in this case. Although an uneven
distribution of melanin with the alternating melanin and fibrous
bands within the tumors seen in 4 cases in this study might be
considered one of the pathologic features responsible for a T1-SP,
the retrospective nature of this study interfered with an exact 1:1
MR imaging–pathologic correlation; thus, the elucidation of the
exact histopathologic basis for a T1-SP was difficult. We recom-
mend a prospective study focusing on the MR imaging–patho-
logic correlation in a large cohort of patients with SNM in the near
future.
A T1-SP seen in an SNM in the present study looks like the
convoluted cerebriform pattern seen in inverted papillomas.23
The only difference is that the former is best seen on T1WI, while
the latter is seen on T2WI and contrast-enhanced T1WI. A “con-
voluted cerebriform pattern” is the term first used in the pathol-
ogy literature by Barnes et al24 to describe a distinctive gross
mucosal morphology of inverted papilloma, created by the juxta-
posed epithelial and stromal layers. This peculiar mucosal mor-
phology results in a characteristic pattern onMR imaging (ie, the
alternating hypointense and hyperintense bands on T2-weighted
and contrast-enhanced T1-weighted images), making the imag-
ing diagnosis of inverted papilloma possible.23,25 Histologically,
the convoluted cerebriform pattern seen in inverted papilloma is
known to result from the alternation of highly cellularmetaplastic
epithelium and less cellular edematous stroma.25
This study has several limitations. First, the case series of
SNMs is small, and the number of SNMs that underwent a histo-
pathologic review is even smaller. Second, we used varying imag-
ing parameters and different magnets in this study. These might
alter the results of the prevalence of T1-SP because a higher mag-
netic field strength causes a greater sensitivity to T1 shortening.
Third, the histopathologic features responsible for T1-SP were
not exactly determined because the retrospective nature of this
study prevented us fromperforming histopathologic re-examina-
tion in all cases of SNM,making an exact 1:1MR imaging–patho-
logic correlation difficult. Fourth, the proportion of SNMs in-
cluded in this study is roughly 23% (31 of 137), which is much
higher than up to 4% reported among all sinonasal malignant
tumors. The skewed composition of the patients due to the un-
usually high proportion with the disease of interest can have an
unreliable impact on the calculations of the diagnostic index, such
as specificity, positive and negative predictive values, and accu-
racy and thus may not reflect the true values encountered in clin-
ical practice.
CONCLUSIONS
Despite several limitations of this study, a T1-SP might be an
adjunctiveMR imaging finding for distinguishing SNM from var-
ious nonmelanomatous malignant sinonasal tumors with an
overall accuracy of 92%. Although the exact histopathologic fea-
tures responsible for a T1-SP are yet to be determined, we suggest
that itmay be attributed to an uneven distribution ofmelanin and
hemorrhage within the tumors. A prospective study focusing on
the MR imaging–pathologic correlation is highly recommended.
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